News

Activate Science Programme Extends Its Reach Across Europe

LOUGHBOROUGH, England (Nov. 26, 2018) – Activate Science, an annual event series organised by Thermo Fisher Scientific and attended by laboratory personnel across Europe, reached delegates at 36 customer sites in 2018.

Emily Quinton, European Marketing Communications Manager, commented: “Activate Science has reached nearly 3,300 delegates in 10 European countries this year and provides a valuable opportunity to network and experience the latest innovations in laboratory products hands-on at customer sites.”

Air Liquide Making a Difference in Cambridge

Air Liquide is pleased to announce their new site at Waterbeach in Cambridge.

In order to get closer to our customers and provide the service you require we are now closer than ever to your business.

- Expert support in Speciality and Industrial gas applications

- Fast delivery from stock

- All ranges of equipment and design assistance

Email: john.pritchard@airliquide.com

Tel: 07970 234332

Induced Pluripotent Stem Cells for Regenerative Research

AMSBIO announces that induced pluripotent stem (iPS) cell expert - Dr Masato Nakagawa from the Nobel Prize winning Yamanaka Lab** at the Centre for iPS Cell Research and Application, Kyoto University, Japan will give 3 talks in the UK on the 10th and 11th December 2018.

BioIVT Acquires Biological Specialty Corporation, Adds Donor Centers and Increases Its Immune Cell Capacity

Acquisition increases BioIVT’s supply of leukopaks, plasma and sera, and enhances its ability to support the in vitro diagnostic market

Wickham Laboratories Ltd to Exhibit at Pharmig 2018

Wickham Laboratories will be exhibiting at Pharmig’s 26th annual conference held on the 28th & 29th November at the Belfry Hotel, Nottingham.

This year’s event will bring together an array of industry experts and regulators to discuss the latest research and findings within the pharmaceutical microbiology industry.

The conference programme will include the following topics among others:

Charles River to Present Collaborative Methods at Neuroscience 2018

WILMINGTON, Mass.--(BUSINESS WIRE)--Oct. 30, 2018-- Charles River Laboratories International, Inc. (NYSE: CRL) today announced that its team of neuroscience drug discovery experts will present 26 scientific posters, both independently and collaboratively with clients, at Neuroscience 2018, the 48th annual meeting of the Society for Neuroscience (SfN).

Charles River and Distributed Bio Enter Exclusive Partnership to Create an Integrated Antibody Discovery and Development Platform

WILMINGTON, Mass. & SAN FRANCISCO--(BUSINESS WIRE)--Oct.

ARECOR SUCCESSFULLY DEFENDS A KEY EUROPEAN PATENT IN OPPOSITION PROCEEDINGS ON THE SUBJECT OF MITIGATION OF AGGREGATION OF THERAPEUTIC PROTEINS DURING STORAGE”

Cambridge, UK., 30th October 2018: Arecor Ltd (“the Company”), the UK-based leading formulation technology company, focussed on developing superior biopharmaceuticals via the innovative reformulation of proteins and peptides, continues to build a strong patent portfolio protecting the Company’s proprietary technology and product assets.

TTP Ventus introduces the XP Series of micropumps

Cambridge, UK, 30 October 2018: TTP Ventus, manufacturer of the Disc Pump range of multi-award-winning micropumps, today introduced its XP Series, the latest pump products in the Company’s strategic development pipeline. The XP Series offers enhanced performance, efficiency, and a wide operational temperature range to support a more diverse range of applications across the medical, life sciences, environmental and defence sectors.

Microbiotica Attracts Equity Investment from Seventure’s Health for Life Capital™ Fund

Cambridge, UK, 24 October 2018 – Microbiotica, a leading player in microbiome-based therapeutics, today announced that it has attracted an equity investment from Seventure Partners, a leading investor in the microbiome space. This new investment of £4m brings the total equity raised to date to £12m.

My Account